164 related articles for article (PubMed ID: 17704536)
1. Expression of oncofetal fibronectin mRNA in thyroid anaplastic carcinoma.
Takano T; Ito Y; Matsuzuka F; Miya A; Kobayashi K; Yoshida H; Miyauchi A
Jpn J Clin Oncol; 2007 Sep; 37(9):647-51. PubMed ID: 17704536
[TBL] [Abstract][Full Text] [Related]
2. Preoperative diagnosis of thyroid papillary and anaplastic carcinomas by real-time quantitative reverse transcription-polymerase chain reaction of oncofetal fibronectin messenger RNA.
Takano T; Miyauchi A; Yokozawa T; Matsuzuka F; Maeda I; Kuma K; Amino N
Cancer Res; 1999 Sep; 59(18):4542-5. PubMed ID: 10493503
[TBL] [Abstract][Full Text] [Related]
3. Quantitative measurement of telomerase reverse transcriptase, thyroglobulin and thyroid transcription factor 1 mRNAs in anaplastic thyroid carcinoma tissues and cell lines.
Takano T; Ito Y; Matsuzuka F; Miya A; Kobayashi K; Yoshida H; Miyauchi A
Oncol Rep; 2007 Sep; 18(3):715-20. PubMed ID: 17671725
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of miR-138 is associated with overexpression of human telomerase reverse transcriptase protein in human anaplastic thyroid carcinoma cell lines.
Mitomo S; Maesawa C; Ogasawara S; Iwaya T; Shibazaki M; Yashima-Abo A; Kotani K; Oikawa H; Sakurai E; Izutsu N; Kato K; Komatsu H; Ikeda K; Wakabayashi G; Masuda T
Cancer Sci; 2008 Feb; 99(2):280-6. PubMed ID: 18201269
[TBL] [Abstract][Full Text] [Related]
5. [Aspiration biopsy-RT-PCR(ABRP): lesson from its success].
Takano T; Amino N
Rinsho Byori; 2001 Dec; 49(12):1248-54. PubMed ID: 11797396
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation of transcription elogation factor A (SII) like 4 (TCEAL4) in anaplastic thyroid cancer.
Akaishi J; Onda M; Okamoto J; Miyamoto S; Nagahama M; Ito K; Yoshida A; Shimizu K
BMC Cancer; 2006 Nov; 6():260. PubMed ID: 17076909
[TBL] [Abstract][Full Text] [Related]
7. Rapid detection of specific messenger RNAs in thyroid carcinomas by reverse transcription-PCR with degenerate primers: specific expression of oncofetal fibronectin messenger RNA in papillary carcinoma.
Takano T; Matsuzuka F; Sumizaki H; Kuma K; Amino N
Cancer Res; 1997 Sep; 57(17):3792-7. PubMed ID: 9288789
[TBL] [Abstract][Full Text] [Related]
8. Expression of nestin mRNA is a differentiation marker in thyroid tumors.
Yamada H; Takano T; Ito Y; Matsuzuka F; Miya A; Kobayashi K; Yoshida H; Watanabe M; Iwatani Y; Miyauchi A
Cancer Lett; 2009 Jul; 280(1):61-4. PubMed ID: 19268442
[TBL] [Abstract][Full Text] [Related]
9. Thyroid transcription factor-1 in normal, hyperplastic, and neoplastic follicular thyroid cells examined by immunohistochemistry and nonradioactive in situ hybridization.
Katoh R; Kawaoi A; Miyagi E; Li X; Suzuki K; Nakamura Y; Kakudo K
Mod Pathol; 2000 May; 13(5):570-6. PubMed ID: 10824930
[TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein e expression in anaplastic thyroid carcinoma.
Ito Y; Takano T; Miyauchi A
Oncology; 2006; 71(5-6):388-93. PubMed ID: 17690558
[TBL] [Abstract][Full Text] [Related]
11. Oncofoetal fibronectin--a tumour-specific marker in detecting minimal residual disease in differentiated thyroid carcinoma.
Hesse E; Musholt PB; Potter E; Petrich T; Wehmeier M; von Wasielewski R; Lichtinghagen R; Musholt TJ
Br J Cancer; 2005 Sep; 93(5):565-70. PubMed ID: 16091757
[TBL] [Abstract][Full Text] [Related]
12. Expression of oncofetal fibronectin messenger ribonucleic acid in fibroblasts in the thyroid: a possible cause of false positive results in molecular-based diagnosis of thyroid carcinomas.
Takano T; Miyauchi A; Matsuzuka F; Kuma K; Amino N
J Clin Endocrinol Metab; 2000 Feb; 85(2):765-8. PubMed ID: 10690888
[TBL] [Abstract][Full Text] [Related]
13. Galectin-3 and oncofetal-fibronectin expression in thyroid neoplasia as assessed by reverse transcription-polymerase chain reaction and immunochemistry in cytologic and pathologic specimens.
Giannini R; Faviana P; Cavinato T; Elisei R; Pacini F; Berti P; Fontanini G; Ugolini C; Camacci T; De Ieso K; Miccoli P; Pinchera A; Basolo F
Thyroid; 2003 Aug; 13(8):765-70. PubMed ID: 14558920
[TBL] [Abstract][Full Text] [Related]
14. Decreased type 1 iodothyronine deiodinase expression might be an early and discrete event in thyroid cell dedifferentation towards papillary carcinoma.
de Souza Meyer EL; Dora JM; Wagner MS; Maia AL
Clin Endocrinol (Oxf); 2005 Jun; 62(6):672-8. PubMed ID: 15943828
[TBL] [Abstract][Full Text] [Related]
15. INSL-3 is expressed in human hyperplastic and neoplastic thyrocytes.
Hombach-Klonisch S; Hoang-Vu C; Kehlen A; Hinze R; Holzhausen HJ; Weber E; Fischer B; Dralle H; Klonisch T
Int J Oncol; 2003 May; 22(5):993-1001. PubMed ID: 12684664
[TBL] [Abstract][Full Text] [Related]
16. Biological role and potential therapeutic targeting of the chemokine receptor CXCR4 in undifferentiated thyroid cancer.
De Falco V; Guarino V; Avilla E; Castellone MD; Salerno P; Salvatore G; Faviana P; Basolo F; Santoro M; Melillo RM
Cancer Res; 2007 Dec; 67(24):11821-9. PubMed ID: 18089812
[TBL] [Abstract][Full Text] [Related]
17. Blood presence of circulating oncofetal fibronectin mRNA, by RT-PCR, does not represent a useful specific marker for the management and follow-up of thyroid cancer patients.
Vendittelli F; Raffaelli M; Fadda G; Carelli-Alinovi C; Paolillo C; Bellantone R; Zuppi C; Capoluongo E
Clin Chem Lab Med; 2012 Jan; 50(4):715-20. PubMed ID: 22505562
[TBL] [Abstract][Full Text] [Related]
18. Accurate and objective preoperative diagnosis of thyroid papillary carcinomas by reverse transcription-PCR detection of oncofetal fibronectin messenger RNA in fine-needle aspiration biopsies.
Takano T; Miyauchi A; Yokozawa T; Matsuzuka F; Liu G; Higashiyama T; Morita S; Kuma K; Amino N
Cancer Res; 1998 Nov; 58(21):4913-7. PubMed ID: 9809999
[TBL] [Abstract][Full Text] [Related]
19. Heterogeneous distribution of thyrotrophin receptor messenger ribonucleic acid (TSH-R mRNA) in papillary thyroid carcinomas detected by in situ hybridization.
Tanaka K; Inoue H; Miki H; Komaki K; Monden Y
Clin Endocrinol (Oxf); 1996 Mar; 44(3):259-67. PubMed ID: 8729520
[TBL] [Abstract][Full Text] [Related]
20. Measurement of the expression of oncofetal fibronectin mRNA in thyroid carcinomas by competitive reverse transcription-polymerase chain reaction.
Higashiyama T; Takano T; Matsuzuka F; Liu G; Miyauchi A; Yokozawa T; Morita S; Kuma K; Shiba E; Noguchi S; Amino N
Thyroid; 1999 Mar; 9(3):235-40. PubMed ID: 10211598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]